ロード中...
Keeping the Ball In Bounds
The notion of ‘one drug, many uses’ may drive sales and give hope to sick patients who are willing to try anything. But the government’s crackdown on off-label promotion has biotech companies carefully watching their step, even as CMS policy appears to encourage scientific study of off-label use....
保存先:
| 第一著者: | |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioCommunications LLC
2004
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3570984/ https://ncbi.nlm.nih.gov/pubmed/23424296 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|